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Abstract
Background: Excessive release of chelatable zinc from excitatory synaptic vesicles is involved in the pathogenesis of
selective neuronal cell death following transient forebrain ischemia. The present study was designed to examine the
neuroprotective effect of a membrane-permeable zinc chelator, clioquinol (CQ), in the CA1 region of the gerbil
hippocampus after transient global ischemia.
Methodology/Principal Findings: The common carotid arteries were occluded bilaterally, and CQ (10 mg/kg, i.p.) was
injected into gerbils once a day. The zinc chelating effect of CQ was examined with TSQ fluorescence and
autometallography. Neuronal death, the expression levels of caspases and apoptosis inducing factor (AIF) were evaluated
using TUNEL, in situ hybridization and Western blotting, respectively. We were able to show for the first time that CQ
treatment attenuates the ischemia-induced zinc accumulation in the CA1 pyramidal neurons, accompanied by less neuronal
loss in the CA1 field of the hippocampus after ischemia. Furthermore, the expression levels of caspase-3, -9, and AIF were
significantly decreased in the hippocampus of CQ-treated gerbils.
Conclusions/Significance: The present study indicates that the neuroprotective effect of CQ is related to downregulation of
zinc-triggered caspase activation in the hippocampal CA1 region of gerbils with global ischemia.
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Introduction
Transient global ischemia, which often occurs during cardiac
arrest when the brain is deprived of oxygen and glucose for a short
period of time, involves several mechanisms of delayed neuronal
cell death, such as excitotoxicity, free radical reaction, mitochon-
drial dysfunction, inflammation, and neuronal apoptosis [1,2,3].
Certain brain regions, especially the hippocampal CA1 field, are
selectively vulnerable to transient global ischemia [4,5,6].
Interestingly, recent studies suggest that release of synaptic zinc
from the zinc-containing excitatory neurons plays a key role in
hippocampal neuronal death during cerebral ischemia [7].
In the brain, zinc is mostly bound to proteins, including
metalloenzymes and transcription factors, where it plays catalytic
or structural roles [8,9]. Chelatable zinc is located in presynaptic
vesicles in a subset of glutamatergic axonal terminals throughout
the mammalian forebrain, especially the hippocampus and cortex
[10]. Under physiological conditions, synaptically released zinc
serves as a neuromodulator and modulates the activity of
postsynaptic receptors. In some pathological conditions, such as
transient cerebral ischemia, zinc translocation from presynaptic
terminals into postsynaptic neuronal cell bodies contributes to the
pathogenesis of delayed selective neuronal cell death [11].
Importantly, several studies have shown that chelation of zinc in
vivo protects against zinc-induced neuronal death in cerebral
ischemic animal models. For instance, injection of a zinc chelator,
Ca-EDTA, significantly reduces caspase-3 activity and neuronal
death resulting from damage caused by global ischemia [11,12].
Another zinc chelator, DP-b99, has been shown to have
neuroprotective properties in animal models as well as stroke
patients [13,14]. These data suggest that zinc chelators are
promising agents for neuroprotective therapy after ischemic stroke.
Clioquinol (5-chloro-7-iodo-8-hydroxyquinoline, CQ) is a
membrane-permeable and hydrophobic metal chelator [15]. It
can selectively bind zinc and copper with greater affinity than
calcium and manganese, and can easily cross the blood-brain
barrier [15]. Moreover, unlike traditional chelators, CQ is seen as
acting to restore biometal homeostasis rather than causing a bulk
excretion and is now understood to include a metal chaperone or
ionophore activity. CQ could bring metals captured into nearby
cells and this activity is most associated with anti-cancer property
[16,17] and decreased interstitial Ab [18,19]. Following oral
treatment, CQ can significantly reduce the brain b-amyloid
burden and can improve the memory impairment of aged AD
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trials have shown that CQ has positive effects on AD patients
[20,21,22]. Therefore, CQ, with its properties in modulation of
cellular biometal metabolism, is being used as a candidate
therapeutic strategy for AD [23]. In addition, it is also confirmed
that CQ has positive effects in animal models of Parkinson’s
disease and Huntington’s disease [24,25].
Although the importance of zinc in ischemic neuronal death and
the effect of zinc chelation in zinc-induced cell death have been
clearly demonstrated, the beneficial effects of CQ have not been
investigated in global cerebral ischemia. Therefore, the present
study was undertaken to explore the neuroprotective potential
of CQ, with special concentration on the inhibition of zinc
accumulation in CA1 pyramidal neurons and caspase activity in
the hippocampus, in global cerebral ischemia in Mongolian gerbils.
Results
Chelating effects of CQ on free zinc ions in the gerbil
hippocampus
To evaluate the chelatable zinc accumulation and the chelating
effects of CQ on zinc ions in the ischemic gerbil hippocampus, we
first employed zinc-specific fluorescence indicator dye, N-6-
(methoxy-8-quinolyl)-para-toluenesulfonamide (TSQ), on hippo-
campal sections at 3 days after ischemia. In the sham control,
intense TSQ fluorescence was found in the mossy fibers from the
dentate gyrus (DG) to the CA3 region (Figure 1A), and the CA1
region showed a faint TSQ fluorescence (Figure 1B). In the vehicle-
treated ischemic gerbil hoppocampus, clear TSQ fluorescence
appeared in the pyramidal neurons of the CA3 region (Figure 1C,
D), which is consistent with previous findings that global ischemia
leads to a pronounced accumulation of TSQ fluorescence in cell
bodies of CA1 pyramidal neurons at 3 days after ischemia [26]. In
the CQ-treated ischemic gerbil hippocampus, TSQ fluorescence
wasmarkedly reduced not only inthe mossy fiberterminals,butalso
in the cell bodies of CA1 pyramidal neurons (Figure 1E, F).
We also performed immersion autometallography (AMG)
staining to further examine the zinc chelating effects of CQ in
the ischemic gerbil hippocampus. Since the AMG development
procedure is very sensitive to temperature and other parameters,
the brain sections from sham control, vehicle-treated and CQ-
treated ischemic gerbils were incubated in the AMG developer in
the same jar at the same time. Furthermore, sodium diethyldithio-
carbamate trihydrate (DEDTC) treatment was carried out, and no
AMG-positive staining of brain sections was observed (data not
shown), suggesting the specificity of the zinc staining in our
immersion AMG staining [27]. In the sham and vehicle-treated
gerbils, intense AMG staining was observed in the mossy fibers of
the hippocampus (Figure 2A, C). However, the zinc staining in
mossy fiber terminals was markedly reduced following CQ
treatment (Figure 2E). Importantly, the ischemia-induced zinc
accumulation in CA1 pyramidal neurons was very marked in the
vehicle-treated ischemic gerbil brain (Figure 2D). In contrast, CQ
treatment resulted in virtually no zinc labeling in the cell bodies of
CA1 pyramidal neurons (Figure 2F). Consistent with the TSQ
fluorescence results, these findings indicate that CQ attenuated the
ischemia-induced zinc sequestration in CA1 pyramidal neurons.
CQ protects against neuronal loss and apoptosis in the
hippocampus
Global ischemia-induced neuronal loss was assessed by histolog-
ical examination of Nissl staining. Consistent with previous reports
[6], extensive neuronal changes in the CA1 regions of the
hippocampus were noted in ischemic gerbil brain. More shrunken
Figure 1. TSQ staining showing the zinc chelating effect of CQ in the gerbil hippocampus. (A–F) TSQ fluorescence dye staining in the
hippocampus at 3 d after sham-operation (A, B), and in vehicle-treated (C, D), and CQ-treated ischemic gerbils (E, F). Intense zinc fluorescence was
observed in the mossy fiber terminals from the DG to the CA3 region. Global ischemia increased the TSQ fluorescence in the CA1 area (C). Striking
accumulation of zinc fluorescence was observed in the cell bodies of pyramidal neurons (C, D). Treatment with CQ significantly reduced chelatable
zinc in hippocampal mossy fibers and the CA1 region (E, F). Arrows indicate TSQ fluorescence in the pyramidal neuronal cell bodies. CA1:
hippocampal CA1 area; CA3: hippocampal CA3 area; DG: dentate gyrus. Scale bars =500 mm (A, C, E), 25 mm (B, D, F).
doi:10.1371/journal.pone.0011888.g001
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gerbils, compared with sham controls (Figure 3A). CQ treatment
markedly increased the number of surviving neurons with palely
stained nuclei and Nissl substance, compared with vehicle-treated
gerbils (Figure 3A). The quantitative results showed that the average
numbers of surviving cells in the hippocampal CA1 region of CQ-
treated ischemic gerbils were significantly increased compared with
those in vehicle-treated controls (p,0.01, Figure 3B).
We further assessed the hippocampal neuronal apoptotic
damage by terminal deoxynucleotidyl transferase-mediated dUTP
nick end-labeling (TUNEL) staining to determine the changes in
the number of neurons showing DNA breaks. As shown in Figure
4, there were very few TUNEL-positive neurons in the CA1
region of the hippocampus of sham control gerbils (Figure 4A).
Vehicle-treated ischemic gerbils had many more TUNEL-stained
cell nuclei in the CA1 region of the hippocampus (Figure 4B),
whereas CQ-treated gerbils had less TUNEL-positive neurons in
the hippocampal CA1 region (Figure 4C). Quantitative results
revealed that the average numbers of TUNEL-positive nuclei in
the hippocampal CA1 region in CQ-treated gerbils were
significantly reduced compared with those in vehicle controls
(p,0.01, Figure 4D). Taken together, both Nissl and TUNEL
staining results indicate that treatment with CQ is able to protect
against neuronal cell death in the hippocampal CA1 region
following an insult produced by transient global ischemia.
CQ inhibits the activity of caspase-3, caspase-9 and AIF in
the hippocampus
To examine whether CQ could modulate the expression of
apoptosis-related proteins in the hippocampus, in situ hybridiza-
tion of caspase-3 and caspase-9 was performed on hippocampal
sections from sham control, vehicle-treated and CQ-treated
ischemic gerbils (Figure 5). In the CA1 region of the sham control
hippocampus, few caspase-3- and caspase-9-positive neurons could
be observed (Figure 5A, E). However, in vehicle-treated ischemic
gerbils, the number of caspase-3- and caspase-9-stained cells was
markedly elevated (Figure 5B, F), whereas CQ treatment
significantly reduced the number of caspase-positive neurons
(Figure 5C, G). Quantitative results indicated that the number of
both caspase-3- and caspase-9-positive cells in CQ-treated
ischemic gerbils was significantly reduced in the CA1 region of
the hippocampus, compared with that in vehicle-treated ischemic
gerbils (p,0.01, Figure 5D, H).
The expression level of caspase-3 in the hippocampus was further
examined using Western blot immunoassay. It is known that
caspase-3 is a cytosolic protein and an inactive proenzyme, and is
activated by proteolytic cleavage into active subunits. As shown in
Figure 6A, the checked proteins were detected in bands located at
32 kDa for procaspase-3 and 20 kDa for cleaved caspase-3 in the
gerbil hippocampus. Statistical analyses showed that there were
significant reductions in the expression levels of both cleaved
caspase-3 (active) and procaspase-3 (inactive) in CQ-treated
ischemic hippocampi at 1, 3, and 7d, respectively, compared with
vehicle-treated controls (p,0.0520.01, Figure 6B, C).
Apoptosis inducing factor (AIF) is a pro-apoptotic protein
associated with caspase-independent neuronal cell apoptosis, and
is involved in hippocampal neuronal apoptosis in the ischemic
gerbil [28]. Thus, we examined the effect of CQ on the expression
of AIF in the hippocampus of the ischemic gerbil using Western
blot assay. Our immunoblot results showed that AIF was detected
Figure 2. AMG staining showing that CQ injection markedly reduces chelatable zinc in the gerbil hippocampus. (A–F) Zinc AMG
staining in the hippocampus at 3 d after ischemia. Distinct zinc staining was detected in the hippocampal mossy fibers in sham control (A, B) and
vehicle-treated ischemic gerbils (C, D). CQ treatment markedly reduced the zinc staining in the mossy fibers from the DG to the CA3 region (E).
Consistent with TSQ fluorescence dye staining, massive accumulation of zinc was observed in the cell bodies of CA1 pyramidal neurons in vehicle-
treated ischemic gerbils (D), whereas CQ injection markedly reduced chelatable zinc in CA1 pyramidal neurons (F). Arrows indicate zinc-containing
pyramidal neuronal cell bodies. CA1: hippocampal CA1 area; CA3: hippocampal CA3 area; DG: dentate gyrus. Scale bars =500 mm (A, C, E), 25 mm (B,
D, F).
doi:10.1371/journal.pone.0011888.g002
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ischemia, CQ treatment significantly reduced the level of AIF in
the ischemic hippocampus, compared with the vehicle-treated
control (p,0.05-0.01, Figure 7B). Taken together, these results
indicate that the neuroprotective effects of CQ in the hippocam-
pus of the ischemia gerbil may be due to regulating both caspase-
dependent and -independent apoptosis signaling pathways.
Discussion
It is well known that global ischemia causes delayed neuronal
death in the selectively vulnerable hippocampal CA1 region and,
most interestingly, a delayed zinc rise after ischemic insult but
before the onset of cell death is observed in the CA1 neurons
[11,26,29]. At 3 d after ischemia, the accumulation of zinc is
massively increased in CA1 pyramidal neurons [26], indicating
that the delayed accumulation of zinc is involved in delayed
neuronal death in the gerbil brain. It has been suggested that
reduction of zinc accumulation in neurons with a high-affinity zinc
chelator, Ca-EDTA, is beneficial for preventing neuronal death
after transient cerebral ischemia [11,26]. In an ischemia rat model,
accumulation of zinc was observed specifically in degenerating
neurons in the hippocampus, and intraventricular injection of Ca-
EDTA could reduce zinc accumulation and prevent hippocampal
neurodegeneration [11]. Administration of Ca-EDTA markedly
attenuated the late rise in zinc and cell death in the hippocampal
CA1 region at 3 days after ischemia in the gerbil [26]. In the
present study, we extended our experiments to assess the chelating
effects of a zinc chelator, CQ, on the ischemic gerbil hippocampus.
Both TSQ fluorescence dye and AMG staining, which are widely
employed to demonstrate loosely bound or chelatable zinc ions
[30,31], were employed to assess the effects of CQ on chelatable
zinc pools in the gerbil brain. Consistent with a previous report
[32], our data showed that CQ reduced the density of TSQ
fluorescence and AMG staining in the mossy fibers, suggesting that
intraperitoneal treatment of CQ rapidly targets chelatable zinc
pools in the hippocampus of the gerbil brain [32]. Most im-
portantly, we showed for the first time that CQ attenuates
ischemia-induced zinc accumulation, accompanied by less delayed
neuronal death in the CA1 field revealed by Nissl and TUNEL
staining. These findings indicate that CQ can target a reduction in
delayed zinc accumulation, and is a potential therapeutic
approach to preventing neuronal death after transient global
ischemia.
The underlying mechanisms whereby zinc is involved in
delayed neuronal death and the neuroprotective effects of CQ
after ischemic insult are still obscure. In a hippocampal slice model
with oxygen-glucose deprivation, zinc rapidly enters neurons,
accumulates in mitochondria, and contributes to consequent
mitochondrial dysfunction and cell death [33,34], suggesting
caspase-dependent neuronal apoptosis after a toxic zinc insult. In
the present study, we measured the expression levels of caspase-3
and caspase-9, two key molecules in the caspase-dependent
apoptotic cascade, in the ischemic gerbil hippocampus. Our
results showed that ischemic insult markedly increased the number
of both caspase-3- and caspase-9-positive neurons in the
hippocampal CA1 region 3 days after global ischemia. Together
with our TSQ and AMG data and previous reports that increased
zinc accumulation in the CA1 neurons was observed after
transient cerebral ischemia [26], it is reasonable to speculate that
the ischemia-induced zinc rise may trigger the activity of caspases
in the CA1 neurons and, consequently, lead to neuronal death. In
addition, our data also showed that transient ischemia resulted in
an increased level of AIF, a pro-apoptotic mitochondrial molecule
Figure 3. Nissl staining showing the neuroprotective effect of CQ on the pyramidal cells in the gerbil hippocampal CA1 region. (A)
The number of surviving neurons with round and palely stained nuclei in the CA1 region was increased in CQ-treated gerbils, compared with vehicle-
treated controls, at day 1, 3 and 7 post-ischemia. Arrows indicate the dark shrunken damaged neurons. Scale bars =25 mm. (B) Cell densities were
represented on the graphs by counting surviving cells per field under a light microscope, and a significant increase in the numbers of pyramidal
neurons in the CA1 were observed in CQ-treated gerbils at day 1, 3 and 7 post-ischemia. ** p,0.01 (n=6).
doi:10.1371/journal.pone.0011888.g003
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pathway [35]. This indicates that ischemia-induced zinc accumu-
lation plays a role in modulating caspase-independent neuronal
death following transient cerebral ischemia. In the present study,
we further assessed the effects of CQ on modulating the caspase-
dependent and -independent death pathways in the hippocampus
of the ischemic gerbil. Our data showed that administration of CQ
significantly reduced the expression levels of caspase-3, -9, as well
as AIF in the hippocampus, 3 days after ischemia in the gerbil.
These findings indicate that the neuroprotective effect of CQ
involves regulation of caspase-dependent and -independent death
pathways, through reducing the delayed accumulation of zinc in
the vulnerable neurons in the hippocampus of the ischemic gerbil.
However, CQ could also act by alternative pathways involving
modulation of cellular biometal metabolism. After administration
of CQ, the normalization of zinc and copper reuptake in the
glutamatergic synapse may improve the function of the NMDA
receptor and restore long-term potentiation (LTP) [18]. The
ionophoric activity of CQ has been shown to activate PI3K-Akt
pathway through a mechanism that involves raising cellular metal
levels [19], which might lead to neurons survival in the
hippocampus of the ischemic gerbil, too. Moreover, CQ-zinc
complex can cross the plasma membrane and intrcellular
membranes, thereby decrease the free zinc concentration of
cytoplasm by transport zinc to intracellular organelles such as
mitochondria and lysosomes, which induced cancer cells apopto-
sis, but not normal cells [16]. Thus, there are other mechanisms of
CQ involved in neuroprotective effects after ischemic insult.
In summary, we present data showing that administration of the
zinc chelator, CQ, markedly reduces chelatable zinc accumula-
tion, prevents neurodegeneration, and is accompanied by
downregulation of zinc-triggered caspase-3, -9, and AIF activation
in the gerbil hippocampus after ischemic insult. The present study
indicates that the neuroprotective effect of CQ, likely involves
modulation of both caspase-dependent and -independent apoptot-
ic pathways.
Materials and Methods
Ethics statement
All efforts were made to minimize animal suffering and the
number of animals used. The experimental procedures were
carried out in accordance with the regulations of the animal
protection laws of China and approved by the animal ethics
committee of China Medical University (JYT-20060948).
Animals and treatment
Adult male Mongolian gerbils weighing 60–80 g were used in
this study. They were housed under a 12 h light/dark cycle with
water and food available ad libitum.
The surgical procedure to produce transient global ischemia
was carried out according to the method described previously with
minor modification [36,37]. Briefly, gerbils were anesthetized
intraperitoneally (i.p.) with pentobarbital (40 mg/kg) and a 2.5 cm
ventral neck incision was made. The bilateral common carotid
arteries were separated carefully from the vagus nerves and were
occluded bilaterally for 10 min with non-traumatic aneurysm
clips. Then, the aneurysm clips were removed and complete
reperfusion of the arteries was confirmed by direct visual
observation. After suturing the neck incision area, gerbils were
kept under a heating lamp for 2 h until they recovered. CQ
(10 mg/kg, i.p., Sigma) or vehicle (DMSO, Sigma) was injected
into the gerbils immediately after cerebral ischemia and then was
given once a day untill the animals were sacrificed. The sham-
operated non-ischemia gerbils underwent the same surgical
procedures, except that the bilateral common carotid arteries
were not occluded. All efforts were made to minimize the number
of animals used and their suffering.
TSQ fluorescence staining
TSQ (Molecular Probes, Eugene, OR) fluorescence dye staining
was carried out as described previously [38,39]. Briefly, three days
after the production of transient global ischemia, gerbils (n=6 in
each group) were given the last injection of CQ or vehicle and, one
hour later, the animals were sacrificed by giving an overdose of
pentobarbital. The brains were removed immediately and
cryosections (20 mm) were prepared. The sections were immersed
Figure 4. TUNEL staining showing that CQ treatment leads to
less apoptotic neurons in the gerbil hippocampal CA1 region.
(A–C) The TUNEL-positive cells in the hippocampal CA1 region were
examined at 3 d after ischemia. Compared with sham controls (A), more
TUNEL-positive apoptotic neurons were observed in vehicle-treated
ischemic gerbils (B), while the number of TUNEL-positive cells was
markedly reduced in ischemic gerbils treated with CQ (C), compared
with vehicle-treated gerbils. Scale bar =25 mm. (D) TUNEL-positive
neurons in the CA1 region were counted under a light microscope.
Statistically significant reduction in the number of TUNEL-positive
apoptotic neurons in the CA1 region were found in CQ-treated gerbils,
compared with vehicle-treated controls. ** p,0.01 (n=6).
doi:10.1371/journal.pone.0011888.g004
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sodium acetate buffer (pH 10) for 90 s, followed by washing with
normal saline for 60 s. TSQ fluorescence was observed under a
fluorescence microscope with an ultraviolet filter.
Zinc autometallography
T h ei m m e r s i o nA M Gw a sp e r f o r m e da sw ed e s c r i b e dp r e v i o u s l y
[40]. Three days after surgery, the gerbils (n=6 in each group)
received an injection of CQ or vehicle. One hour later, they were
sacrificed and their brains were carefully removed. Fresh brain slices
(2 mm) were prepared with a vibratome and immersed in NTS
solution containing 0.1% sodium sulphide and 3% glutaraldehyde in
0.1 M phosphate buffer (PBS, pH 7.4) for 72 h at 4uC. After rinsing
withPBS,the brainsliceswere immersed in30%sucroseovernightat
4uC, and were then cut into 20 mm coronal sections in a cryostat. Five
sections from each animal were selected and were incubated in the
AMG developer in the same jar at 26uCf o r6 0m i n .T h eA M G
developer was prepared as described previously [41]. After several
rinses in distilled water, the sections were dehydrated, covered, and
analyzedwithalightmicroscopeequippedwithadigitalcamera.The
DEDTC (Merck) control procedure was performed as reported
previously [27], to confirm the specificity of the zinc staining.
Nissl staining
At 1, 3 and 7 d post-surgery, the gerbils in each group (n=6)
were perfused transcardially with 4% paraformaldehyde in 0.1 M
PBS. Their brains were then removed and embedded in paraffin
according to standard protocols. When the intact morphology of
the hippocampus was found in a section, it was considered as the
beginning. Thus, seven series of paraffin sections (7 mm) were
prepared and 5 series of sections were selected for Nissl, TUNEL,
caspase-3, csapase-9, and HE staining, respectively.
For Nissl staining, sections were immersed in 0.1% cresyl violet at
37uC for 20 min. After rinsing with distilled water, sections were
dehydrated, fitted with coverslips and examined with a light
microscope. To assess neuronal survival in the CA1 region, neurons
Figure 5. In situ hybridization detection of caspase-3 and -9 in the gerbil hippocampal CA1 region. (A–G) The caspase-3- (A–C) and
caspase-9-positive neurons (E–G) in the hippocampal CA1 region were analyzed at 3 d after ischemia. The numbers of both caspase-3- and caspase-9-
positive neurons were massively increased in vehicle-treated ischemic gerbils (B, F), compared with sham controls (A, E). In the CQ-treated ischemic
gerbils, the numbers of caspase-3- (C) and caspase-9-positive cells (G) were markedly reduced compared with vehicle-treated gerbils. Scale bar
=25mm. (D, H) Statistical analysis showed that the numbers of both caspase-3- and caspase-9-positive neurons were significantly reduced in CQ-
treated gerbils, compared with that in vehicle controls. ** p,0.01 (n=6).
doi:10.1371/journal.pone.0011888.g005
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while shrunken cells with pyknotic nuclei were considered as not
surviving. Five brain sections were selected from each animal and
processed for counting. Data were expressed as the number of
surviving cells/field, as we reported previously [42].
TUNEL staining
TUNEL staining of paraffin sections was performed according
to the manufacturer’s protocol (Roche, Germany). Briefly, sections
of gerbil brain were incubated with 2% H2O2 in PBS for 5 min,
and with a 20 mg/ml proteinase K working solution for 15 min at
37uC. After rinsing with 0.1 M PBS, sections were incubated in
the TUNEL reaction mixture for 60 min at 37uC in a humidified
atmosphere in the dark. The Converter-POD was added to the
sections for 30 min at 37uC. After rinsing, sections were incubated
with 0.025% 3,39-diaminobenzidine plus 0.0033% H2O2 for
10 min. After rinsing, sections were counterstained with hema-
toxylin and examined with a light microscope. To assess TUNEL-
positive cell expression, brown grains clustered over hematoxylin
stained cells were counted and analyzed. Five brain sections were
selected from each animal (n=6) and cell counting was carried
out. Data were expressed as the number of TUNEL-positive cells/
field. As a negative control, the step using the TUNEL reaction
mixture was omitted, and a nucleotide mixture in reaction buffer
was used instead.
In situ hybridization
In situ hybridization was carried out using a commercially
available kit (Boster Biological Technology), with high-perfor-
mance liquid chromatography (HPLC)-purified oligonucleotide
probes specific for caspase-3 and caspase-9 mRNA. The mRNA
expression was assessed on paraffin sections of brain at the level of
the hippocampus from sham, vehicle- and CQ-treated ischemic
gerbils at 3 d after the insult. Sections were acetylated, and
Figure 6. Expression levels of caspase-3 proteins in the gerbil
hippocampus. (A) Representative images of immunoblots are shown
with antibodies against caspase-3 and GAPDH. GAPDH was used as a
loading control. (B, C) Compared with vehicle-treated ischemic
controls, the expression levels of both cleaved caspase-3 (B) and
procaspase-3 (C) proteins were reduced significantly in the CQ-treated
ischemic gerbil hippocampus at 1, 3, and 7 d after ischemia. * p,0.05,
** p,0.01 (n=6).
doi:10.1371/journal.pone.0011888.g006
Figure 7. Expression level of AIF protein in the gerbil
hippocampus. (A) The protein level of AIF in the hippocampus was
measured at 1, 3 and 7 d after ischemia. Representative images of
immunoblots are shown with antibodies against AIF and GAPDH.
GAPDH was used as a loading control. (B) The expression level of AIF
protein was significantly reduced in the CQ-treated ischemic gerbil
hippocampus at 1 and 3 d after ischemia, compared with vehicle-
treated ischemic controls. No significant difference in AIF level was
detected between vehicle- and CQ-treated ischemic gerbil hippocam-
pus at 7 d after ischemia. * p,0.05, ** p,0.01 (n=6).
doi:10.1371/journal.pone.0011888.g007
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with the probes of caspase-3, and caspase-9 at 40uC, overnight.
After rinsing, sections were treated with confining liquid at 37uC
for 30 min. Then the ABC kit was applied for 1 h at room
temperature, and a brown color appeared in the sections after
incubation of the sections in 0.025% DAB with 0.0033% H2O2 for
10 min. Further processing of the stained sections was as described
above. As a control, sections were incubated with a nonsense
probe, which resulted in no detectable signal.
Western blot analysis
Hippocampi isolated from gerbil brains were homogenized at a
ratio of 1:4 (w/v) in an ice-cold lysis buffer (50 mM Tris–HCl,
150 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 0.25% sodium
deoxycolate, 0.1% SDS, 1 mM phenylmethylsulfonyl fluoride,
10 mg/ml leupeptin, 1 mM Na3VO4, and 1 mM NaF). The
resulting homogenate was centrifuged at 12,000 g for 30 min at
4uC. The supernatant was collected and total protein levels were
measured using a BCA protein assay kit (Pierce Biotechnology).
Sample protein (30 mg) was separated on 10% SDS-polyacryl-
amide gels and transferred onto PVDF membranes (Milipore).
The membranes were blocked with 5% nonfat milk in TBS
containing 0.05% Tween 20 for 2 h and then incubated with
primary antibody for 2 h at room temperature. The dilutions of
primary antibodies were 1:500 for caspase-3 (Santa Cruz) and AIF
(Santa Cruz), and 1:12,000 for GAPDH (Kang Chen). Then,
membranes were washed and incubated in HRP-conjugated goat
anti-rabbit antibody (1:5000) or HRP-conjugated goat anti-mouse
antibody (1:5000) for 1 h. Immunolabeled protein bands were
detected using an enhanced chemiluminiscence system. Films were
digitized using a scanner, and the relative optical density of the
bands was determined with Image Scion software 4.03.
Statistical analysis
All statistical analyses were carried out using an SPSS 13.0
software package. All values were represented as mean 6 SD.
Student’s t-test was used for comparison between vehicle control
and CQ treatment groups at each time point. p,0.05 was
considered statistically significant.
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